A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele

计划入组 17 人 · 首次发布于 2019 年 10 月 15 日

A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele

计划入组 17 人 · 首次发布于 2019 年 10 月 22 日

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy

首次发布于 2013 年 10 月 11 日

Cystic Fibrosis Foundation Commits Additional $24 Million to Prime Medicine for Gene Editing Therapy Development